Translational Cancer Research
| 短名 | Transl Cancer Res TCR |
| Journal Impact | 1.30 |
| 国际分区 | ONCOLOGY(Q4) |
| 期刊索引 | SCI Q4中科院 4 区 |
| ISSN | 2218-676X, 2219-6803 |
| h-index | 39 |
| 国内分区 | 医学(4区)医学肿瘤学(4区) |
TRANSLATIONAL CANCER RESEARCH (TRANSL CANCER RES TCR; PRINT ISSN: 2218-676X; ONLINE ISSN 2219-6803; HTTP://TCR.AMEGROUPS.COM/) 是一本开放获取的同行评审期刊，在 SCIENCE CITATION INDEX EXPANDED (科学技术研究所）。 TCR 发表新治疗干预的实验室研究以及评估癌症新治疗模式的临床试验；将实验室和临床环境联系起来的新型研究调查的结果，包括风险评估、细胞和分子表征、预防、检测、诊断和治疗人类癌症，总体目标是改善癌症患者的临床护理。 TCR 的重点是原创的、经过同行评审的、以科学为基础的研究，这些研究成功地将临床医学推向提高患者“生活质量”的目标。编辑和一个由科学家和临床医生科学家以及其他专家组成的国际咨询小组将将 TCR 文章保持在高质量标准。我们接受原创文章以及评论文章、社论和简要文章。
期刊主页投稿网址| 涉及主题 | 医学生物内科学遗传学癌症病理化学生物化学肿瘤科癌症研究外科基因免疫学放射科数学 |
| 出版信息 | 出版商: AME Publishing Company，出版周期: ，期刊类型: journal |
| 基本数据 | 创刊年份: 2012，原创研究文献占比: 80.82%，自引率:6.70%， Gold OA占比: 99.74% |
期刊引文格式
这些示例是对学术期刊文章的引用，以及它们应该如何出现在您的参考文献中。
并非所有期刊都按卷和期组织其已发表的文章，因此这些字段是可选的。有些电子期刊不提供页面范围，而是列出文章标识符。在这种情况下，使用文章标识符而不是页面范围是安全的。
只有1位作者的期刊
有2位作者的期刊
有3位作者的期刊
有5位以上作者的期刊
书籍引用格式
以下是创作和编辑的书籍的参考文献的示例。
学位论文引用格式
网页引用格式
这些示例是对网页的引用，以及它们应该如何出现在您的参考文献中。
专利引用格式
最新文章
Characterization and validation of a prognostic model for the N6-methyladenosine-associated ferroptosis gene in colon adenocarcinoma
2024-8-1
Feasibility and safety of transarterial chemoembolization in patients with liver cancer via the distal radial approach: a single-center retrospective cohort study
2024-8-1
Fourth-generation epidermal growth factor receptor-tyrosine kinases inhibitors: hope and challenges
2024-8-1
Integrated analysis of the lncRNA-miRNA-mRNA ceRNA network in nasopharyngeal carcinoma
2024-8-1
Analysis of the ideal cutoff age as a predictor of differentiated thyroid cancer using the Surveillance, Epidemiology, and End Results database
2024-8-1
AIBP promotes cell proliferation and migration through the ERK1/2-MAPK signaling pathway in hepatocellular carcinoma
2024-8-1
Efficacy and safety of immune checkpoint inhibitors plus platinum-etoposide vs. platinum-etoposide in the first-line treatment of extensive-stage small cell lung cancer: a systematic review and a meta-analysis
2024-8-1
Bioinformatic prediction of miR-320a as a potential negative regulator of CDGSH iron-sulfur domain 2 (CISD2), involved in lung adenocarcinoma bone metastasis via MYC activation, and associated with tumor immune infiltration
2024-8-1
A novel tumor-derived exosomal gene signature predicts prognosis in patients with pancreatic cancer
2024-8-1
GGT5 as a promising prognostic biomarker and its effects on tumor cell progression in gastric cancer
2024-8-1
A nomogram for overall survival of second primary cancers following upper-tract urothelial carcinoma: a SEER population-based study
2024-8-1
The expression of tumor necrosis factor receptor 2 is correlated with the prognosis of cancer: a systematic review and meta-analysis
2024-8-1
Unveiling the role of RARs in stomach adenocarcinoma: clinical implications and prognostic biomarkers
2024-8-1
Trimodality therapy in the modern era for management of bladder cancer
2024-8-1
The role of chromatin modulator DPY30 in glucose metabolism of colorectal cancer cells
2024-8-1
Low-dose apatinib optimizes the vascular normalization and enhances the antitumor effect of PD-1 inhibitor in gastric cancer
2024-8-1
Effect of Agkistrodon acutus venom (AAVC-I) on apoptosis through modulation of the Keap1/Nrf2 pathway in HSC-3 oral squamous cell carcinoma cells
2024-8-1
Bioinformatics analysis of SH2D4A in glioblastoma multiforme to evaluate immune features and predict prognosis
2024-8-1
Development of an immunogenic cell death-related lncRNAs signature for prognostic risk assessment in gastric cancer
2024-8-1
TSPAN1 overexpression as an indicator of poor prognosis in estrogen receptor-positive breast cancer
2024-8-1
Identifying epithelial-mesenchymal transition-related genes as prognostic biomarkers and therapeutic targets of hepatocellular carcinoma by integrated analysis of single-cell and bulk-RNA sequencing data
2024-8-1
Treatment of appendiceal neuroendocrine tumour: a controversial treatment for a misunderstood neoplasm in a mysterious organ
2024-8-1
The peripheral CD4+ T cells predict efficacy in non-small cell lung cancer (NSCLC) patients with the anti-PD-1 treatment
2024-8-1
Development and validation of a diagnostic and prognostic model for bone metastasis of intrahepatic cholangiocarcinoma: a population-based analysis
2024-8-1
Bioinformatics analysis-based mining of potential markers for inflammatory bowel disease and their immune relevance
2024-8-1
Hsa_circ_0002360 promotes the progression of lung adenocarcinoma by activating miR-762 and regulating PODXL expression
2024-8-1
PA-MSHA exerts potent activity against cetuximab-resistant colorectal cancer through the miR-7-5p/Akt3/Wnt-β-catenin pathway
2024-8-1
The potential role of breast MRI in evaluation of triple-negative breast cancer and fibroadenoma of less than 3 cm
2024-8-1
Identification of genes predicting chemoresistance and short survival in ovarian cancer
2024-8-1
Special tissue microbiota such as Cyanobacteria are associated with the immune microenvironment of lung adenocarcinoma
2024-8-1
Effectiveness of Paxlovid in the treatment of the SARS-CoV-2 Omicron variant infection in children with hematologic malignancies: a retrospective cohort study
2024-8-1
Exploring the therapeutic potential of simvastatin in pancreatic neuroendocrine neoplasms: insights into cell cycle regulation and apoptosis
2024-8-1
Long non-coding RNA MIR4435-2HG promotes pancreatic cancer progression by regulating ABHD17C through sponging miR-128-3p
2024-8-1
Diagnostic and prognostic role of microRNA-525 in different cancers: a systematic review and meta-analysis
2024-8-1
Erratum to erratum to miR-3614-3p suppresses cell aggressiveness of human breast cancer by targeting AKT3 and HDAC1 expression
2024-8-1
The diagnostic performance of the Mindray system in detecting CA125 and HE4 for patients with ovarian cancer
2024-8-1
Predictive model of gene expression regulating invasion and migration of M2 macrophages in breast cancer: clinical prognosis and therapeutic implications
2024-8-1
An ensemble learning model for predicting cancer-specific survival of muscle-invasive bladder cancer patients undergoing bladder preservation therapy
2024-8-1
The expression of programmed cell death ligand 1 (PD-L1) involves in the clinicopathologic characteristics and prognostic implications of testicular germ cell tumor (TGCT): a systematic review and meta-analysis
2024-8-1
Comprehensive pan-cancer analysis reveals CDC6 as a potential immunomodulatory agent and promising therapeutic target in pancreatic cancer
2024-8-1
Upregulation of CKS2 in immunosuppressive cells is associated with metastasis and poor prognosis in prostate cancer: a single-cell RNA-sequencing analysis
2024-8-1
Integrative analysis of the role of the DPH gene family in hepatocellular carcinoma and expression validation
2024-8-1
Expression profiles of serum transfer RNA-derived fragments and their potential roles in non-small cell lung cancer
2024-7-1
Machine learning-based integration of CD8 T cell-related gene signatures for comprehensive prognostic assessment in lung adenocarcinoma
2024-7-1
Novel mitochondrial-related gene signature predicts prognosis and immunological status in glioma
2024-7-1
Dendritic cell-related hub genes in head-and-neck squamous cell carcinoma: implications for prognosis and immunotherapy
2024-7-1
Integrating network pharmacology and computational biology to propose Yiqi Sanjie formula’s mechanisms in treating NSCLC: molecular docking, ADMET, and molecular dynamics simulation
2024-7-1
LncRNA CBR3-AS1 is associated with the BCR::ABL1 kinase independent mechanism of tyrosine kinase inhibitor (TKI) resistance in chronic myeloid leukemia patients
2024-7-1
Identifying key pathogenic mechanisms and potential intervention targets for recurrence after laryngeal cancer treatment through bioinformatics screening
2024-7-1
SLC12A8 upregulation promotes colorectal cancer progression and chemoresistance
2024-7-1
帮你贴心管理全部的文献
研飞ivySCI，高效的论文管理
投稿经验分享
分享我的经验，帮你走得更远